MedTrace Logo

Analysis of Bioenergetics and Fatigue Responses in Basketball (TEAM)

NCT07250555 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2025-11-26

No results posted yet for this study

Summary

The aims of the study are:

1. To examine skeletal muscle and blood metabolites during an official basketball game and to relate those to skeletal muscle performance during and after the game.
2. To investigate whether skeletal muscle and blood metabolites are related to game-induced fatigue.
3. To relate field activity during a basketball game with the responses of skeletal muscle and blood metabolites.
4. To investigate how blood lactate reflects muscle lactate concentration during a basketball game.
5. To determine whether temporary fatigue develops during a basketball game. game.

Conditions

  • Metabolic Stress

Interventions

OTHER

BASKETBALL GAME

Participants will arrive 1.5 hours pre-game for initial vastus lateralis muscle biopsies and blood sampling under local anesthesia (20 mg/ml xylocaine without adrenalin). They will be fitted with IMU sensors and heart rate monitors. Volunteers are randomly assigned to teams(6 teams) for a full 40-minute game. During the match, physiological measurements will be performed at fixed times (pre, at half-time, and post-match) and after intense exercise periods (HR\>90% max, high-speed runs\>18km/h) within the four 10-min periods. Three groups provide samples: Group 1 (n=15): rest, half-time, end-game. Group 2 (n=8): rest, post-intense period in 1st/3rd periods. Group 3 (n=7): rest, post-intense period in 2nd/4th periods. Ten players serve as substitutes. Games will start at 17.00 - 18 p.m. to avoid diurnal variations and will be held under normal environmental conditions. A standardized 30-min warm-up period will be performed before each game.

Sponsors & Collaborators

  • University of Southern Denmark

    collaborator OTHER

  • Democritus University of Thrace

    collaborator OTHER

  • University of Thessaly

    lead OTHER

Study Design

Allocation
NA
Purpose
BASIC_SCIENCE
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
30 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2025-05-30
Primary Completion
2025-11-30
Completion
2026-02-28

Countries

  • Greece

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07250555 on ClinicalTrials.gov